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Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmunity with unknown 
etiology and continuous relapse periods depending on several factors including environmental 
and host genetics [1]. Patients with SLE have an immune response against different intercellular 
antigens leading to immune complexes and sediments in vascular parts of different body organs. 
Immune sediments cause local inflammation and tissue damage that leading to heightening auto-
immune response. Patients with SLE cause an immune response against a variety of antigens. This 
response leads to the creation of immune complexes that precipitate in various vascular organs of 
the body. Sedimentation of the immune complexes causes local inflammation and tissue damage 
that may aggravate the immune response [2].
In recent studies, there was particular attention to levels of vitamin D and its role in different 
diseases. It has been observed that vitamin D levels is associated with some of chronic diseases 
such as cardiovascular diseases, malignancy and many other autoimmunity diseases such as type 1 
diabetes mellitus, inflammatory bowel disease (IBD), Multiple Sclerosis, undifferentiated connective 
tissue disease, rheumatoid arthritis (RA) and SLE [3]. It is also observed that serum vitamin D levels 
has a reverse relationship with SLE activity scores [4-6].
Recent studies showed that vitamin D had main role in the physiologic condition of body and its 
deficiency related with chronic diseases such as calcium disorders, cancers, cardiovascular diseases 
and auto-immune diseases [7,8].
Many studies recently done on the role of vitamin D in the modulating the activity of the 
immune system [9-11].
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Abstract
Background: In different studies, the correlation between systemic lupus erythematosus (SLE) and disease 
activity with vitamin D has been shown. Also, low level of vitamin D and interferon alpha was associated with 
psychological disorders but there wasn’t more evidence about the relationship between vitamin D deficiency and 
psychological disorders.
Objective: This study aimed to investigate Relationship between serum vitamin D level, interferon alpha and 
psychological disorders in patients with SLE.
Methods: In this cross-sectional descriptive study, 50 SLE patients were recruited. Serum 25-OH Vitamin 
D concentration and IFN-α levels and also, levels of SLEDAI were measured. Statistical methods were used to 
determine the correlation between vitamin D and IFN-α and also the correlation between INF-α with Depression, 
Stress and Anxiety scores in SLE patients. 
Results: Vitamin D deficiency (<40 nmol/L) was detected in 20% of SLE patients. The mean Vitamin D 
and INF-α in SLE patients was 23.94 ± 11.93 and 396.60 ± 54.73, respectively. There was significantly negative 
correlation between vitamin D and depression (r=-0.479, p=0.001) and Anxiety (r=-0.34, p=0.01) but the relation 
between vitamin D and stress wasn’t significant. Of all SLE patients, 56% had depression, 64% had anxiety and 
66% had stress in very severe level. 
Conclusion: Results showed that the level of vitamin D was negatively correlated with depression and 
anxiety of patients. Also, it seems that, by increasing the QOL of patients and decreasing the rate of depression 
and anxiety in SLE patients we could improve the vitamin D level and then SLEDAI.
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Vitamin D supplementation in SLE patients was associated 
with decrease in inflammatory cytokines and markers: IL-1, IL-
6, IL-18, TNF-α, erythrocyte sedimentation rate (ESR); vitamin 
D supplementation was also associated with a reduction in 
autoantibodies and elevation in complement level [12,13]. Vitamin 
D treatment enhanced T-reg cells and production of T helper 2 
cytokines; a correlation was found between disease activity and 
change in 25(OH)D in deficient patients following treatment; and 
vitamin D treatment even showed improvement in disease activity 
and fatigue among juvenile-onset SLE [14-16].
IFN-α can be a marker of disease activity and low levels in treated 
patients can express the response to treatment. Vitamin D levels 
have reverse relationship with disease activity. So, it is possible that 
there would be a relationship between IFN-α levels and vitamin D 
levels in patients with SLE. There is only one study investigating 
this relationship and expressing that there is an obvious negative 
relationship between vitamin D levels and IFN-α level, so that with 
high level of vitamin D, IFN-α is low and disease has lower activity 
[17]. This study aims at investigating the relationship between vitamin 
D and IFN-α level with disease activity in SLE patients.
Material and Methods
Study design and population
This cross-sectional descriptive study was approved in code 
IR.ARUMS.REC.169 by Ardabil University of Medical Science ethics 
committee in Ardabil a province in northwest of Iran and carried out 
on 50 patients with lupus in Imam Khomeini Hospital in Ardabil. All 
patients provided written informed consent and measurement of 25-
OH vitamin D level and definition of insufficiency were taken from 
all participants. 
Inclusion and exclusion criteria
For this study, we recruited all patients who fulfilled the 
revised American College of Rheumatology (ACR) criteria for the 
classification of SLE. 
Measurement of vitamin D
The serum vitamin D were measured by ELISA kit related to the 
Euroimmun lübeck from Germany country and serum interferon 
alpha levels were measured by the ELISA of Bender MedSystems, Inc. 
Burlingame, California. All measurements done by the guideline of 
each manufactory. The amount of Vitamin D less than 30 ng/mLwe 
considered as a deficiency.
Measurement of disease activity index SLEDAI
We used the systemic lupus erythematosus disease activity index 
(SLEDAI) questionnaire for diseases activity index which had score 
between 1 and 8 based on clinical examination by a clinician and 
occurrence of some disorders. 
Measurement of Depression, stress and anxiety
We used the Depression Anxiety Stress Scales (DASS) standard 
questionnaire included 21 questions for depression, anxiety and 
stress each with 7 item and each item scored between 0 to 3 and their 
levels classified form normal to very severe based on scores. 
Statistical analysis
Collected data were analyzed using descriptive statistical methods 
(frequency, percentage, Mean±SD). Also we checked the normality 
of distribution for all data by K-S test and then we used Pearson 
correlation test and scatter plot for obtain the relationship between 
quantitative variables such as 25-Oh Vitamin D and dsDNA, SLEDAI 
scores, DASS21 and INF-α. A p<0.05 was considered as significant. 
All data analyzed in SPSS version 16.
Ethical Approve
This study financially supported by Ardabil University of Medical 
Science and approve in the ethical committee and registered by code 
IR.ARUMS.REC.2017.169.
Results
In this research, 50 patients with SLE were evaluated. The mean of 
depression, anxiety and stress based on DASS21 was 15.5 ± 9.9, 15.7 
± 9.3 and 18.8 ± 9.1, respectively. Most of cases had depression, stress 
and anxiety in very sever level (Table 1).
There was a meaningful reverse correlation between vitamin 
D level and depression (r=-0.479, p=0.001) and anxiety (r=-0.34, 
p=0.01) but the correlation between INF-α and depression, stress, 
anxiety wasn’t significant (Table 2 and Figures 1-4). 
Table 1: The levels of Anxiety, stress and depression in SLE patients.














Stress Very severe 33(66)
Table 2: Correlation between Vitamin D level and clinical characteristics of SLE 
patients.
Variables
With Vitamin D With INF-α
R p-value r p-value
INF-α -0.413 0.003
SLEDAI -0.492 0.001 0.358 0.01
Age -0.02 0.8 -0.16 0.3
Depression -0.479 0.001 0.004 0.98
Anxiety -0.34 0.01 -0.008 0.96
Stress -0.22 0.1 -0.017 0.91
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Figure 1: Correlation between vitamin D and Depression.
Figure 3: Correlation between INF-α and Anxiety.
Table 3: Clinical characteristics of SLE patients by level of vitamin D.
Vitamin D levels Normal Insufficient p-valueVariables
Age 32.4±6.7 34.4±9.6 0.54
M
        Sex
1 (10%) 4 (10.3%)
0.98
F 9 (90%) 35 (89.7%)
INF-α 164.4±19.85 437.5±64.5 0.03
SLEDAI 3.2±1.23 10.4±5.2 0.001
Depression 3.2±1.23 17.5±9.5 0.003
Anxiety 9.6±2.5 16.7±9.1 0.02
Stress 14.6±12 19.8±8.1 0.11
Low level of compliant 1(10%) 22(56.4%) 0.01
Figure 2: Correlation between vitamin D and Anxiety.
Figure 4: Correlation between INF-α and Depression.
Also, we observed that the mean of general depression score in 
SLE people with normal vitamin D level with 3.2 ± 1.23 significantly 
lower than SLE people with Insufficient vitamin D level with 17.5 ± 
9.5. (p=0.03) (Table 3).
Page 4/5
Gr   upSM Copyright  Azami A
Citation: Enteshari-Moghaddam A, Azami A, Mohammadi-Kebar Y and Sadeghieh-Ahari S. 
Relationship between Serum Vitamin D Level, Interferon Alpha and Psychological Disorders in Patients 
with SLE (Systemic Lupus Erythematosus). SM J Neurol Neurosci. 2019; 5(1): 1027.
Discussion
It is also observed that 20% of SLE patients had normal vitamin 
D level, 78% had insufficiency and only 2% had deficiency. Low levels 
of vitamin D in SLE patients has been reported in Schoindre et al 
study that reported vitamin D deficiency in 15.9% and insufficiency 
in 65.9% of SLE patients [4]. A recent report showed an approximate 
vitamin D3 deficiency in two third and deficiency (less than 10 ng/ml) 
in about one fifth of SLE patients [18].
Low levels of vitamin D3 in SLE patients comparing healthy 
people was reported in different societies [19]. In present study, it 
is observed that lupus patients significantly had lower vitamin D 
level than healthy people in society. Normal level vitamin D in SLE 
patients was lower than society. Similarly, Hamza et al., observed than 
vitamin D levels in SLE patients were significantly lower than control 
group [6].
Vitamin D insufficiency is a common finding among Iranians. In 
a review study, Heshmat expressed that vitamin D insufficiency in 
Iranian males and females have been 76.1% and 72.1%, respectively 
[20]. Based on different studies, vitamin D insufficiency varies in 
different parts of country which can explained through geographical 
and local situation, kind of clothing and nutrition in each area [21-
23].
Low levels of vitamin D could not be a factor for producing and 
progressing SLE, but its low levels can worsen the disease. In present 
study, a meaningful negative correlation was observed between 
vitamin D level and SLEDAI (r=-0.492, p=0.001). Low levels of 
vitamin D are associated with higher SLEDAI (r=-0.492, p=0.001) 
and higher anti-dsDNA levels (r=-0.417, p=0.003).
Sumethkul et al.[24], Hamza et al., [6] and Schoindre et 
al.[4] observed that low vitamin D level had a meaningful reverse 
correlation with higher SLEDAI. Also, Mandal et al in a study showed 
that vitamin D level had a meaningfully reverse correlation with 
SLEDAI and anti-dsDNA [17]. Also, in some studies, no relationship 
was reported between vitamin D and SLEDAI [25,26].
By studying the levels of depression, anxiety and stress in SLE 
patients and their relation with vitamin D and INF-α we observed 
that there was an inverse correlation between vitamin D and anxiety 
and depression rate but the correlation between INF-α and depression 
and anxiety wasn’t significant. Gholamrezaei et al in a study showed 
that vitamin D level had significant correlation with physical activity 
index and anxiety of patients but not correlated with depression [27].
Studies showed that the vitamin D deficiency was more common 
among people with severe and very severe anxiety and after 
improvement the vitamin D level in these patients their depression 
and anxiety levels promoted [28].
A systematic review on SLE patients showed that prevalence of 
anxiety and depression in these patients were very high about twice 
more than society [29].
Sotodeh-Asl et al., in a study showed that there wasn’t more 
evidence for determine the significant relationship between low level 
of vitamin D and psychological disorders which wasn’t in line with 
our study results because in current study we showed that there was 
an inverse correlation between depression and anxiety and vitamin 
D levels [30].
Conclusions
Results showed that the level of vitamin D was negatively 
correlated with depression and anxiety of patients. Also, it seems 
that, by increasing the QOL of patients and decreasing the rate of 
depression and anxiety in SLE patients we could improve the vitamin 
D level and then SLEDAI. 
Limitations
In this study case-control study we not separated the cases with 
active disease from case with controlled disease, so we could not 
stated certainty the role of low level of vitamin D in these two groups. 
Another limitation of this study was the low sample size.
Recommendation
According to the results of this study, the measure of vitamin D 
in all SLE patients recommended and in all patients with a low level 
of vitamin D, starting treatment has been recommended for improve 
their condition and accompanying symptoms. 
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